AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $998,178 | +74.0% | 14,282 | -4.2% | 0.33% | +68.9% |
Q2 2023 | $573,730 | -38.5% | 14,902 | -1.5% | 0.19% | -33.2% |
Q1 2023 | $933,342 | +84.0% | 15,132 | +14.8% | 0.29% | +8.6% |
Q4 2022 | $507,315 | -14.0% | 13,177 | -1.0% | 0.27% | -9.5% |
Q3 2022 | $590,000 | +15.0% | 13,312 | +1.0% | 0.29% | +9.7% |
Q2 2022 | $513,000 | -4.6% | 13,177 | +0.6% | 0.27% | -2.9% |
Q1 2022 | $538,000 | +7.0% | 13,102 | -0.6% | 0.28% | +12.2% |
Q4 2021 | $503,000 | +16.2% | 13,177 | 0.0% | 0.25% | +5.1% |
Q3 2021 | $433,000 | – | 13,177 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |